176 related articles for article (PubMed ID: 26928825)
1. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
[TBL] [Abstract][Full Text] [Related]
4. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
Bernardo BC; Gao XM; Tham YK; Kiriazis H; Winbanks CE; Ooi JY; Boey EJ; Obad S; Kauppinen S; Gregorevic P; Du XJ; Lin RC; McMullen JR
PLoS One; 2014; 9(2):e90337. PubMed ID: 24587330
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
[TBL] [Abstract][Full Text] [Related]
6. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
7. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R
J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
10. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
12. Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload.
Wu C; Dong S; Li Y
Int J Mol Med; 2015 Apr; 35(4):893-900. PubMed ID: 25695617
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
[TBL] [Abstract][Full Text] [Related]
15. The Degree of Cardiac Remodelling before Overload Relief Triggers Different Transcriptome and miRome Signatures during Reverse Remodelling (RR)-Molecular Signature Differ with the Extent of RR.
Rodrigues PG; Miranda-Silva D; Li X; Sousa-Mendes C; Martins-Ferreira R; Elbeck Z; Leite-Moreira AF; Knöll R; Falcão-Pires I
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353134
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
18. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
20. miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.
Yin X; Peng C; Ning W; Li C; Ren Z; Zhang J; Gao H; Zhao K
Mol Cell Biochem; 2013 Jul; 379(1-2):1-6. PubMed ID: 23660952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
